Global Medicines for Smoking Cessation Market Expected To Reach 2.6 $billion by 2019

Date: 2016-09-19

In 2014, the global smoking cessation medicine market had an estimated value of $2.19 billion. Estimated revenues in 2015 will be $2.26 billion. The market will observe growth after 2015 with a CAGR of 3.6% to reach $2.6 billion in 2019.

Reducing the prevalence of smoking is a national agenda of many nations, including emerging markets. This development provides an opportunity to manufacturers and marketers of smoking cessation medicines to expand organically. Smokers who are not physiologically dependent on nicotine and are ready to quit are more likely to respond to behavioural interventions than dependent patients. Most current smokers are likely to be significantly nicotine dependent, so it is appropriate to consider drug therapy to help them quit.

Drugs for smoking cessation are including Nicotine replacement therapy, Varenicline, Bupropion, Personalising drug treatment, Electronic cigarettes and Cannabis. There are three approved drug therapies in Australia – varenicline, bupropion and nicotine replacement therapy, because other drug therapies efficacy is not as good as that of the approved drugs.

According to survey, more people are becoming aware of the risks associated with tobacco use. Around six million users of tobacco die every year and this number is set to increase to eight million by 2030. Cancer, cardiovascular diseases, diabetes, and chronic respiratory diseases are also caused due to tobacco use. Tobacco smoke consists of over 4,000 chemical compounds, with about 69 chemicals that are potentially known to cause cancer. These chemicals harm not only smokers, but also second-hand smokers who inhale the smoke in public spaces. Another area where the harmful effects of tobacco are witnessed is in tobacco farming, where young children from underprivileged families are often employed.

Global key manufacturers of Video Content Analytics:


Read Full Report:

Joanna | Executive – International Business and partner Relations
E-mail: | Tel: 510-400-8520


Contact With Us
Join templatemonster at google+
Customized Research
Request Sample